Respiratory Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Clin Infect Dis. 2023 Feb 8;76(3):e1266-e1269. doi: 10.1093/cid/ciac468.
We analyzed 9630 invasive GAS surveillance isolates in the USA. From 2015-2017 to 2018-2019, significant increases in erythromycin-nonsusceptibility (18% vs 25%) and clindamycin-nonsusceptibility (17% vs 24%) occurred, driven by rapid expansions of genomic subclones. Prevention and control of clustered infections appear key to containing antimicrobial resistance.
我们分析了美国 9630 株侵袭性酿脓链球菌监测分离株。从 2015-2017 年到 2018-2019 年,红霉素不敏感(18%比 25%)和克林霉素不敏感(17%比 24%)显著增加,这是由基因组亚克隆的快速扩张驱动的。聚集性感染的预防和控制似乎是控制抗菌药物耐药性的关键。